Video

Breast Cancer Treatment – Prof. Andrew Tutt on the OlympiA Trial

June 14 2021

| Taken from The Institute of Cancer Research, YouTube

Video

Breast Cancer Treatment – Prof. Andrew Tutt on the OlympiA Trial

June 14 2021

| Taken from The Institute of Cancer Research, YouTube

Credit: The Institute of Cancer Research, YouTube

The results of the OlympiA clinical trial, involving ICR researchers, shows giving the drug olaparib for one year to breast cancer patients with inherited BRCA mutations, after they have completed initial treatment, reduced the chance of their breast cancer returning.

Professor Andrew Tutt, Head of Breast Cancer Research at the ICR, explains more.